NRG-GU002

Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel.

For more information about this clinical trial, click here.

Schema & Eligibility NRG-GU002

Available at:

CoxHealth Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
Mercy Hospital, Rolla, MO
Mercy Hospital, St. Louis, MO
Mercy Hospital, Washington, MO
Central Care Cancer Center, Bolivar, MO
Freeman Health Center, Joplin, MO
Phelps County Regional Medical Center, Rolla, MO
Good Samaritan Regional Health Center, Mt. Vernon, IL
Mercy Hospital, Oklahoma City, OK
Mosaic Life Care, St. Joseph, MO

Ask your physician about participating in this clinical trial or call us.